SanBio Company Limited (TYO:4592)
2,166.00
+91.00 (4.39%)
At close: Mar 6, 2026
SanBio Company Market Cap
SanBio Company has a market cap or net worth of 169.02 billion as of March 6, 2026. Its market cap has increased by 148.49% in one year.
Market Cap
169.02B
Enterprise Value
168.41B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,166.00
Market Cap Chart
Since April 8, 2015, SanBio Company's market cap has increased from 77.34B to 169.02B, an increase of 118.54%. That is a compound annual growth rate of 7.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 169.02B | 28.17% |
| Dec 30, 2025 | 131.88B | 147.58% |
| Dec 30, 2024 | 53.27B | 15.83% |
| Dec 29, 2023 | 45.99B | -5.12% |
| Dec 30, 2022 | 48.47B | -7.07% |
| Dec 30, 2021 | 52.16B | -24.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 177.31B |
| PeptiDream | 176.64B |
| Takara Bio | 138.00B |
| Oncolys BioPharma | 82.38B |
| Nxera Pharma | 80.09B |
| Healios K.K. | 56.70B |
| Cuorips | 55.62B |
| Japan Tissue Engineering | 31.19B |